USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 22.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 176.611,77 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 156.716,81 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 290.536,95 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 178.279,90 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 244.667,63 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 88.814,46 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 697.996,03 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 132.753,60 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 860.883,04 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 624.870,06 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 322.311,31 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 520.400,14 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 314.976,72 USD |
| 20.10.2026 | 20.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 63.980,61 USD |
| 20.10.2026 | 20.10.2026 | TD Synnex Corp. | Reyna Thompson | President, North America | Verkauf | 25.111,00 USD |
| 20.10.2026 | 20.10.2026 | TD Synnex Corp. | Reyna Thompson | President, North America | Verkauf | 25.065,00 USD |
| 20.10.2026 | 20.10.2026 | TD Synnex Corp. | Reyna Thompson | President, North America | Verkauf | 149.682,00 USD |
| 20.10.2026 | 20.10.2026 | TD Synnex Corp. | Reyna Thompson | President, North America | Verkauf | 202.303,42 USD |
| 20.10.2026 | 20.10.2026 | TD Synnex Corp. | Reyna Thompson | President, North America | Verkauf | 153.388,20 USD |
| 20.10.2026 | 20.10.2026 | TD Synnex Corp. | Reyna Thompson | President, North America | Verkauf | 48.934,00 USD |
| 20.10.2026 | 20.10.2026 | FB Financial Corp. | Orrin H. Ingram II | Director | Kauf | 716.453,90 USD |
| 20.10.2026 | 20.10.2026 | FB Financial Corp. | Orrin H. Ingram II | Director | Kauf | 821.333,88 USD |
| 20.10.2026 | 20.10.2026 | Hubspot Inc. | Brian Halligan | Director | Verkauf | 2.036.345,00 USD |
| 20.10.2026 | 20.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 122.965,00 USD |
| 20.10.2026 | 20.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 705.033,03 USD |
| 20.10.2026 | 20.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 61.047,54 USD |
| 20.10.2026 | 20.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 121.729,00 USD |
| 20.10.2026 | 20.10.2026 | Qualys, Inc. | Bruce K. Posey | CHIEF LEGAL OFFICER | Verkauf | 11.857,97 USD |
| 20.10.2026 | 20.10.2026 | Qualys, Inc. | Bruce K. Posey | CHIEF LEGAL OFFICER | Verkauf | 85.528,53 USD |
| 20.10.2026 | 20.10.2026 | Qualys, Inc. | Bruce K. Posey | CHIEF LEGAL OFFICER | Verkauf | 46.242,22 USD |
| 20.10.2026 | 20.10.2026 | Qualys, Inc. | Bruce K. Posey | CHIEF LEGAL OFFICER | Verkauf | 6.553,80 USD |
| 20.10.2026 | 20.10.2026 | Qualys, Inc. | Bruce K. Posey | CHIEF LEGAL OFFICER | Verkauf | 1.297,17 USD |
| 20.10.2026 | 20.10.2026 | Qualys, Inc. | Bruce K. Posey | CHIEF LEGAL OFFICER | Verkauf | 15.484,12 USD |
| 20.10.2026 | 20.10.2026 | Cornerstone Strategic Investment Fund, Inc. | Joshua Bradshaw | Vice Chairman and President / Director | Kauf | 97.280,00 USD |
| 20.10.2026 | 20.10.2026 | Cornerstone Total Return Fund Inc. | Joshua Bradshaw | Vice Chairman and President / Director | Kauf | 117.600,00 USD |
| 20.10.2026 | 20.10.2026 | Ellsworth Growth & Income Fund Ltd. | Saba Capital Management, L.P. | 10% Owner | Kauf | 20.843,70 USD |
| 20.10.2026 | 20.10.2026 | NEW Germany Fund Inc. | Saba Capital Management, L.P. | 10% Owner | Kauf | 906.898,05 USD |
| 20.10.2026 | 20.10.2026 | BNY Mellon Strategic Municipal Bond Fund, Inc. | Saba Capital Management, L.P. | 10% Owner | Kauf | 77.528,36 USD |
| 20.10.2026 | 20.10.2026 | BNY Mellon Strategic Municipals, Inc. | Saba Capital Management, L.P. | 10% Owner | Kauf | 44.181,28 USD |
| 20.10.2026 | 21.10.2026 | Nebius Group N.V. | Arne Grimme | Director | Kauf | 24.855,12 USD |
| 20.10.2026 | 20.10.2026 | Nebius Group N.V. | Arne Grimme | Director | Kauf | 24.857,62 USD |
| 20.10.2026 | 20.10.2026 | Oric Pharmaceuticals, Inc. | Dominic Piscitelli | Chief Financial Officer | Verkauf | 189.390,60 USD |
| 20.10.2026 | 20.10.2026 | Verizon Communications Inc. | Kyle Malady | EVP and Group CEO-VZ Business | Verkauf | 48.928,00 USD |
| 20.10.2026 | 21.10.2026 | Pinterest, Inc. | Benjamin Silbermann | Director / 10% Owner | Verkauf | 1.075.350,00 USD |
| 20.10.2026 | 20.10.2026 | Pinterest, Inc. | Benjamin Silbermann | Director / 10% Owner | Verkauf | 1.057.481,25 USD |
| 20.10.2026 | 20.10.2026 | Cirrus Logic, Inc. | Jeffrey W. Baumgartner | EVP, R&D | Verkauf | 125.636,50 USD |
| 20.10.2026 | 20.10.2026 | Synaptics Inc. | Rahul G. Patel | See remarks below / Director | Verkauf | 505.700,10 USD |
| 20.10.2026 | 20.10.2026 | Veraxa Biotech AG - Post De-Spac | Christoph Samuel Ziegler | Director | Kauf | 32.700,00 USD |
| 20.10.2026 | 20.10.2026 | Ziprecruiter, Inc. | Amy Garefis | EVP, Chief People Officer | Verkauf | 35.949,51 USD |
| 20.10.2026 | 20.10.2026 | York Water Co. | Douglas S. Brossman | Director | Kauf | 999,99 USD |